Transdermal Fentanyl for Chronic Pain in AIDS

Slides:

Advertisements

Similar presentations

The Relationship Between Depression and Pain Language in Cancer and Chronic Non- Cancer Pain Patients Thomas C. Sist, DDS, Gerard A. Florio, PhD, Marguerite.

Advertisements

The Treatment of Chronic Cancer Pain in a Cancer Hospital in the Netherlands Rianne de Wit, MS, Frits van Dam, PhD, Ans Vielvoye-Kerkmeer, PhD, Carlien.

Oropharyngeal Mucositis Pain Treatment with Transdermal Buprenorphine in Patients After Allogeneic Stem Cell Transplantation Samuel Vokurka, MD, PhD

Clinical Trial Results with OROS® Hydromorphone

The associations of hemodialysis access type and access satisfaction with health- related quality of life Natalie Domenick Sridharan, MD, MSc, Larry Fish,

Winston C. -V. Parris, MD, Benjamin W. Johnson, MD, Marilyn K

Wen Jing Chung, MD, MS, Gregory H. Pharo, DO

A Case Series of Patients Using Medicinal Marihuana for Management of Chronic Pain Under the Canadian Marihuana Medical Access Regulations Mary E. Lynch,

The Impact of Chronic Pain on Life in the Household

Edmonton, Canada: A Regional Model of Palliative Care Development

Validation of the German Version of the Brief Fatigue Inventory

Interactive Collaborative Consultation Model in End-Of-Life Care

Anita L Comley, PhD, RN, AOCN, Elaine DeMeyer, RN, MSN, AOCN

Development of a self-report screening instrument for assessing potential opioid medication misuse in chronic pain patients Laura L Adams, PhD, Robert.

Oropharyngeal Mucositis Pain Treatment with Transdermal Buprenorphine in Patients After Allogeneic Stem Cell Transplantation Samuel Vokurka, MD, PhD

Cognitive Function Impairment in Patients with Neuropathic Pain Under Standard Conditions of Care Mónica Povedano, MD, Jordi Gascón, MD, Rafael Gálvez,

Driving Ability Under Long-Term Treatment with Transdermal Fentanyl

The Effect of a Multimodal Intervention on Treatment-Related Symptoms in Patients Undergoing Hematopoietic Stem Cell Transplantation: A Randomized Controlled.

An Assessment of the Screening Performance of a Single-Item Measure of Depression From the Edmonton Symptom Assessment Scale Among Chronically Ill Hospitalized.

Self-Reported Constipation in Patients With Advanced Cancer: A Preliminary Report Wadih Rhondali, MD, Linh Nguyen, MD, Lynn Palmer, PhD, Duck-Hee Kang,

Exploring the Meaning of Chronic Rejection After Lung Transplantation and Its Impact on Clinical Management and Caregiving Mi-Kyung Song, PhD, RN, Annette.

Renée A. Harrison, PhD, Seng-jaw Soong, PhD, Heidi L

Reliability and Validity of the Korean Memorial Symptom Assessment Scale—Short Form in Gynecological Cancer Patients Ju-Hee Nho, PhD, RN, Sung Reul Kim,

Jean-Pierre Van Buyten, MD Journal of Pain and Symptom Management

A Systematic Review of Training in Symptom Management in Palliative Care Within Postgraduate Medical Curriculums Pamela Turrillas, MD, MSc, Maria Joao.

Redefining Appropriate Treatment Expectations

Development of a symptom assessment instrument for chronic hemodialysis patients: the dialysis symptom index Steven D Weisbord, MD, Linda F Fried, MD,

Treatment of Cancer Pain with Noninvasive Brain Stimulation

Myra Glajchen, DSW, Marilyn Bookbinder, PhD, RN

Paul A. Sloan, MD, Dwight E. Moulin, MD, FRCP(C), Helen Hays, MD

Barriers to Pain Management in a Community Sample of Chinese American Patients with Cancer Janet Edrington, RN, PhD, Angela Sun, MPH, Candice Wong, MD,

The Role of Patients' Expectations in the Development of Anticipatory Nausea Related to Chemotherapy for Cancer Jane T. Hickok, MD, MPH, Joseph A. Roscoe,

Validation study of the Chinese version of the Brief Fatigue Inventory (BFI-C) Xin Shelley Wang, MD, Xi-Shan Hao, MD, Ying Wang, BS, Hong Guo, MD, Yong-Qin.

Barrie R. Cassileth, PhD, Andrew J. Vickers, PhD

The effect of transdermal fentanyl treatment on serum cortisol concentrations in patients with non-cancer pain Emine Ozyuvaci, MD, Nergis Yanmaz Alnigenis,

Do Interference-Based Cut-Points Differentiate Mild, Moderate, and Severe Levels of 16 Cancer-Related Symptoms Over Time? Sangchoon Jeon, MS, Charles.

Prolonged Treatment with Transdermal Fentanyl in Neuropathic Pain

Methadone Analgesia in Cancer Pain Patients on Chronic Methadone Maintenance Therapy Paolo L Manfredi, MD, Gilbert R Gonzales, Andrea L Cheville, Craig.

Sigridur Gunnarsdottir, RN, PhD, Ronald C

Changing M3G/M6G Ratios and Pharmacodynamics in a Cancer Patient During Long- Term Morphine Treatment Gertrud Andersen, MD, Lona L Christrup, PhD, Per.

The Assessment of Cancer Pain in North India

Cancer Pain Education Journal of Pain and Symptom Management

Transdermal Fentanyl in Opioid-Naive Cancer Pain Patients

Gertrud Andersen, MD, Lona Christrup, PhD, Per Sjøgren, MD

The impact of demographic and disease-specific variables on pain in cancer patients Tone Rustøen, RN, PhD, Sophie D Fosså, MD, Dr Med Sci, Jon Skarstein,

Comparative Efficacy of Oral Extended-Release Hydromorphone and Immediate- Release Hydromorphone in Patients with Persistent Moderate to Severe Pain: Two.

Long-Term Safety of Oral Transmucosal Fentanyl Citrate for Breakthrough Cancer Pain Richard Payne, MD, Paul Coluzzi, MD, Lowell Hart, MD, Mary Simmonds,

A Scale for Measuring Patient Perceptions of the Quality of End-of-Life Care and Satisfaction with Treatment Daniel P. Sulmasy, OFM, MD, PhD, Jessica.

Effect of Recombinant Human Erythropoietin on Quality of Life in Cancer Patients Receiving Chemotherapy Gregoris Iconomou, PhD, Angelos Koutras, MD,

Clinical and Economic Impact of Palliative Care Consultation

Knowledge and Attitudes of Italian Medical Staff Towards the Approach and Treatment of Patients in Pain Marco Visentin, MD, Leonardo Trentin, MD, Roberto.

A Preliminary Study of the Utility of the Brief Hospice Inventory

Clinical Economics Journal of Pain and Symptom Management

Physical Function in Patients with Cancer

Greek McGill Pain Questionnaire

Nathaniel P Katz, MD Journal of Pain and Symptom Management

Pain Management, Controlled Substances, and State Medical Board Policy

Gerd Inger Ringdal, PhD, Marit S Jordhøy, MD, Stein Kaasa, PhD

Multidimensional independent predictors of cancer-related fatigue

Botucatu, Brazil: A Regional Community Palliative Care Model

Scrambler Therapy May Relieve Chronic Neuropathic Pain More Effectively Than Guideline-Based Drug Management: Results of a Pilot, Randomized, Controlled.

Economic Evaluation of the Fentanyl Transdermal System for the Treatment of Chronic Moderate to Severe Pain Deirdre M Neighbors, BA, Timothy J Bell,

Lisa C. Lindley, PhD, RN, Jennifer W. Mack, MD, MPH, Donald J

Depomedroxyprogesterone Acetate for Hot Flashes

Does the Medical Record Cover the Symptoms Experienced by Cancer Patients Receiving Palliative Care? A Comparison of the Record and Patient Self-Rating

Is It the Difference a Day Makes

Cancer Symptom Clusters: A Validation Study

Nausea and Vomiting Remain a Significant Clinical Problem

Distinguishing Patient Satisfaction With Treatment Delivery From Treatment Effect: A Preliminary Investigation of Patient Satisfaction With Symptoms After.

Use of oral and transdermal opioids among patients with metastatic cancer during the last year of life Ariel Berger, MPH, Ellen Dukes, PhD, RN, Meredith.

Presentation transcript:

Transdermal Fentanyl for Chronic Pain in AIDS Gayle Newshan, PhD, RN, CS, ANP, Mathew Lefkowitz, MD Journal of Pain and Symptom Management Volume 21, Issue 1, Pages 69-77 (January 2001) DOI: 10.1016/S0885-3924(00)00238-4

Fig. 1 Pain interference by type of activity (mean ± SE). Item was scored as follows: 0 = pain does not interfere to 10 = pain interferes completely. All differences were significant at P < 0.001. an = 32 Journal of Pain and Symptom Management 2001 21, 69-77DOI: (10.1016/S0885-3924(00)00238-4)

Fig. 2 Satisfaction with pain medication; mean score is based on patient responses to questionnaires completed after each 15-day treatment period (mean ± SE). Items were scored as follows: 1 = least satisfied to 6 = most satisfied Journal of Pain and Symptom Management 2001 21, 69-77DOI: (10.1016/S0885-3924(00)00238-4)